Nanobots to treat bladder cancer

Samuel Sánchez

  • PROJECT LEADER

    Samuel Sánchez

  • HOST ORGANIZATION,
    COUNTRY

    Institut de Bioenginyeria de Catalunya IBEC, Spain

  • DESCRIPTION

    Bladder cancer is one of the ten most common cancers and the fifth most frequent in Spain. Despite current therapies being quite effective, the tumour reappears in 70% of cases and treatments lose their efficacy.

    Faced with this challenge, nanobots can be an excellent vehicle to deliver drugs to the tumour and thus minimise side effects. However, only 0.7% of nanoparticles used in oncology manage to reach their target.

    The project seeks to design self-propelled nanobots that arrive to the tumour cells and deliver the most appropriate drug against bladder cancer. In the future, this technology could be used to treat other types of cancer.

  • PARTNER ORGANIZATIONS

    • Asociación Centro de Investigación Cooperativa en Biomateriales - CIC biomaGUNE, Spain

    • Universitat Autònoma de Barcelona (UAB), Spain

    • Fundació Clínic per a la Recerca Biomèdica, Spain

    • Fundació Catalunya-La Pedrera, Spain

    • Associació Catalana de Comunicació Científica, Spain

  • PROJECT TITLE

    Enzyme propelled nanobots as efficient nanotech platform for bladder cancer therapy

  • BUDGET

    €997,946.5